Long-term cyclosporin A for psoriasis

R. H. Engst; R. Bubl; J. Huber; C. Schober; B. Jessberger

Long-term cyclosporin A for psoriasis

R. H. Engst, R. Bubl, J. Huber, C. Schober, B. Jessberger

Department of Dermatology and Allergology

Technical University of Munich

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

We report on a randomized cyclosporin A (CyA) dose-finding trial: 1.25 mg versus 2.5. mg/kg/day. In context with the results of other trials, we favour a CyA-starting dose of 2.5 mg/kg/day. It is mandatory that all patients should undergo a careful dermatological, physical and laboratory examination before therapy, including a careful monitoring during treatment considering the up to now established guidelines of drug administration to minimize the risk of side-effects.

Original language	English
Pages (from-to)	188-192
Number of pages	5
Journal	Acta Dermatovenerologica Alpina, Pannonica et Adriatica
Volume	3
Issue number	4
State	Published - 1994

Keywords

cyclosporin A
long-term treatment
psoriasis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{952d68f8e562482697ba2015c7817e49,

title = "Long-term cyclosporin A for psoriasis",

abstract = "We report on a randomized cyclosporin A (CyA) dose-finding trial: 1.25 mg versus 2.5. mg/kg/day. In context with the results of other trials, we favour a CyA-starting dose of 2.5 mg/kg/day. It is mandatory that all patients should undergo a careful dermatological, physical and laboratory examination before therapy, including a careful monitoring during treatment considering the up to now established guidelines of drug administration to minimize the risk of side-effects.",

keywords = "cyclosporin A, long-term treatment, psoriasis",

author = "Engst, {R. H.} and R. Bubl and J. Huber and C. Schober and B. Jessberger",

year = "1994",

language = "English",

volume = "3",

pages = "188--192",

journal = "Acta Dermatovenerologica Alpina, Pannonica et Adriatica",

issn = "0302-4466",

publisher = "Association of Slovenian Dermatovenerologists",

number = "4",

}

TY - JOUR

T1 - Long-term cyclosporin A for psoriasis

AU - Engst, R. H.

AU - Bubl, R.

AU - Huber, J.

AU - Schober, C.

AU - Jessberger, B.

PY - 1994

Y1 - 1994

N2 - We report on a randomized cyclosporin A (CyA) dose-finding trial: 1.25 mg versus 2.5. mg/kg/day. In context with the results of other trials, we favour a CyA-starting dose of 2.5 mg/kg/day. It is mandatory that all patients should undergo a careful dermatological, physical and laboratory examination before therapy, including a careful monitoring during treatment considering the up to now established guidelines of drug administration to minimize the risk of side-effects.

AB - We report on a randomized cyclosporin A (CyA) dose-finding trial: 1.25 mg versus 2.5. mg/kg/day. In context with the results of other trials, we favour a CyA-starting dose of 2.5 mg/kg/day. It is mandatory that all patients should undergo a careful dermatological, physical and laboratory examination before therapy, including a careful monitoring during treatment considering the up to now established guidelines of drug administration to minimize the risk of side-effects.

KW - cyclosporin A

KW - long-term treatment

KW - psoriasis

UR - http://www.scopus.com/inward/record.url?scp=0028641277&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0028641277

SN - 0302-4466

VL - 3

SP - 188

EP - 192

JO - Acta Dermatovenerologica Alpina, Pannonica et Adriatica

JF - Acta Dermatovenerologica Alpina, Pannonica et Adriatica

IS - 4

ER -

Long-term cyclosporin A for psoriasis

Abstract

Keywords

UN SDGs

Other files and links

Fingerprint

Cite this